文献速递慢病防控与筛查免疫规划

卡介苗接种后强结核菌素反应与多发性硬化低风险相关:一项基于人群的队列研究

Strong tuberculin response after BCG vaccination is associated with low multiple sclerosis risk: a population-based cohort study.
PubMed 文献 · Int J Epidemiol · 2022-01-01

该研究基于挪威1963至1975年结核病筛查项目数据,将卡介苗接种者结核菌素皮肤试验反应大小与挪威多发性硬化登记库中的后续多发性硬化发病相关联,采用Cox比例风险模型和灵活参数生存模型分析。在279891名参与者中,679人后来发生多发性硬化,皮肤硬结每增加4毫米,多发性硬化风险比为0.86(95%CI 0.76-0.96),且该关联在结核菌素试验后持续超过30年。结论认为对卡介苗的强体内疫苗反应与30多年后多发性硬化风险降低相关。

要点

  • 卡介苗接种后结核菌素皮肤试验硬结每增加4毫米,多发性硬化风险比为0.86(95%CI 0.76-0.96)。
  • 该关联在结核菌素试验后持续超过30年。
  • 皮肤硬结大小与多发性硬化风险的关联在男女之间相似。

核心结论

  • 对卡介苗的强体内疫苗反应与30多年后多发性硬化风险降低相关。
  • 决定结核菌素皮肤试验反应性的免疫学机制提示,偏斜的T细胞介导免疫在多发性硬化发病前数十年即已存在。

研究设计与样本

  • 基于挪威结核病筛查项目(1963-1975)数据设计的基于人群的队列研究。
  • 研究将既往接种卡介苗个体的结核菌素皮肤试验反应大小与通过挪威多发性硬化登记库确定的后续多发性硬化发病相关联。
  • 采用Cox比例风险模型和灵活参数生存模型分析结核菌素反应性与多发性硬化风险及其时间关系。
  • 共纳入279891名参与者(52%为女性),其中679人(69%为女性)后来发生多发性硬化。

主要发现

  • 较大的结核菌素皮肤试验反应性与多发性硬化风险降低相关。
  • 皮肤硬结大小每增加4毫米,多发性硬化的风险比为0.86(95%置信区间0.76-0.96),且该关联在男女之间相似。
  • 该关联的强度在结核菌素皮肤试验后持续超过30年。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Multiple sclerosis (MS) is characterized by inflammatory lesions in the central nervous system involving pro-inflammatory T-cells. Immune dysregulation is well described in prevalent disease, but it is not known whether this precedes disease development. Bacillus Calmette-Guérin (BCG) vaccination ameliorates MS-like disease in mice. In people vaccinated with BCG, the tuberculin skin test (TST) offers a standardized measure of a T-cell-mediated immune response. We therefore hypothesized that the strength of the TST response after BCG vaccination is associated with subsequent MS risk. METHODS: Using data from a Norwegian tuberculosis screening programme (1963-1975), we designed a population-based cohort study and related the size of TST reactions in individuals previously vaccinated with BCG to later MS disease identified through the Norwegian MS registry. We fitted Cox proportional hazard models and flexible parametric survival models to investigate the association between TST reactivity, MS risk and its temporal relationship. RESULTS: Among 279 891 participants (52% females), 679 (69% females) later developed MS. Larger TST reactivity was associated with decreased MS risk. The hazard ratio for MS per every 4-mm increase in skin induration size was 0.86 (95% confidence interval 0.76-0.96) and similar between sexes. The strength of the association persisted for >30 years after the TST. CONCLUSION: A strong in vivo vaccine response to BCG is associated with reduced MS risk >30 years later. The immunological mechanisms determining TST reactivity suggest that skewed T-cell-mediated immunity precedes MS onset by many decades.

来源:Int J Epidemiol,查看原文。版权归原作者所有。

引用

  1. Nakken O, Holmøy T, Stigum H, et al. Strong tuberculin response after BCG vaccination is associated with low multiple sclerosis risk: a population-based cohort study. Int J Epidemiol. 2022. PMID: 35278068. doi:10.1093/ije/dyac039

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。